Bitkraft Ventures
BITKRAFT Ventures is a global investment platform specializing in Synthetic Reality™, which they define as the convergence of the physical and digital worlds. They believe that the visionaries in gaming are paving the way for these new experiences by building simulation software and concurrency infrastructure. BITKRAFT sees significant opportunities arising from this convergence, extending beyond entertainment to human fulfillment, ability, and connection. They aim to accelerate the evolution of gaming and empower visionary entrepreneurs who are positioned to benefit from this tectonic shift.
Blockrocket
EGIDE, c’est l’hyper casque : le casque extrême. À[vélo,](velo/)comme à[cheval](collections/casques-equitation/collection-epona-ino-glossy/)ou à[ski](collections/casques-ski/), le casque EGIDE allie des qualités superlatives et habituellement contradictoires : hyper design, mais aussi super léger, incroyablement confortable, très protecteur, résistant dans la durée… Avant EGIDE, cavaliers et cyclistes devaient choisir entre ces qualités. Aujourd’hui, il n’y a plus qu’à choisir le modèle et la couleur…
Blockwall Capital
Blockwall.vc invests in visionary Web3 founders to build a transparent, secure, and inclusive digital future. They focus on early-stage startups solving real-world problems through decentralized technologies, with a disciplined approach to Web3 innovation and long-term value creation.
Boehringer Ingelheim Venture Fund
The Boehringer Ingelheim Venture Fund (BIVF) invests in pioneering science that aims to redefine the standard of care and bring new medicines to patients. As a dedicated Seed/Series A investor with company formation expertise, BIVF primarily invests in pre-clinical assets and platforms. Their activities are closely aligned with Boehringer Ingelheim's strategic interests and promote fostering potential business development targets. BIVF strategically takes a minority shareholder position and requires a voting board seat to actively support their portfolio companies. BIVF aims to redefine standards of care and drive Boehringer Ingelheim's expansion into groundbreaking medical treatments. They are shaping the future of healthcare by supporting transformative areas like Cancer, Regenerative medicine, Auto-immunity, Digital solutions, and Infectious disease. Their strategic investments position BIVF as a leader in propelling innovation. Established in 2010, the BIVF is a €350M evergreen fund with a global presence in the EU, US, and China. They are committed to advancing scientific innovation by investing in first-in-class, disease-modifying therapeutics across various modalities. The fund invests in companies with groundbreaking innovation across Cancer, Regenerative medicine, Auto-immunity indications, Digital solutions, and Infectious disease. BIVF's approach includes taking minority shareholder positions, requiring a voting board seat to actively support portfolio companies, and close alignment with Boehringer Ingelheim's strategic interests, fostering potential business development targets.
Cadence Growth Capital (CGC)
Cadence Growth Capital (CGC) is a growth private equity firm that invests in proven business models alongside founders and experienced investors. They aim to support strong founders and management teams with capital to accelerate growth, targeting companies with technology-enabled business models that generate at least EUR 10 million in revenues, demonstrate strong organic growth rates, and have recurring revenue models with attractive unit economics. CGC's investment platform provides access to the growth private equity asset class for both individual and institutional investors. The firm is funded by leading institutional investors, including insurance companies, family offices, and fund-of-funds, as well as a network of over 200 high-caliber individuals from the founder, corporate finance, investment, and corporate community. CGC invests in both influential minority and majority positions, tailored to the specific needs of each investment. The firm believes value generation is achieved through growth and cashflows and builds a balanced portfolio of disruptive proven companies and established businesses with transformational capabilities. CGC places emphasis on tech-enabled business models, viewing digitalization and technology as key drivers for sustainable success. They possess a strong network within the DACH region through their heritage and investor/partner base, enabling proprietary and early access to attractive companies. CGC operates with a partnership approach, believing in a symbiotic relationship between founders/managers and investors. This involves structuring flexibility and alignment of targets and incentives. Furthermore, CGC prioritizes ESG, promoting environmental and social sustainability in all investments.
Capnamic Ventures
Capnamic Ventures invests in technology companies based in Germany and German-speaking regions, with the goal of supporting them in becoming global category leaders. They believe in the potential of 'Made in Germany' to extend into the digital age and aim to back daring entrepreneurs who can shape the future of technology. Capnamic focuses on early-stage tech startups, offering support from Pre-Seed to Series A rounds, providing hands-on assistance with crucial decisions such as setting up finance departments and making initial executive hires. Their strategy includes leveraging an extensive industry network and providing support functions like marketing and finance to help turn business ideas into fully-fledged companies. They emphasize their deep-rooted network in the German tech scene, with offices in Cologne, Berlin, and Munich. This localized presence gives them a strong understanding of the regional ecosystem. While primarily focused on Germany and the German-speaking regions, they are open to deals elsewhere if they have strong conviction in the company's potential. Capnamic's ultimate goal is to help their portfolio companies scale globally, leveraging their experience and network to provide the resources and guidance needed for success. Capnamic actively supports their portfolio companies, aiming to be the best companion throughout their growth journey. They recognize the importance of their founders' creativity, passion, and drive and aim to fuel this with their support. They have a track record of supporting companies from Seed to IPO, demonstrating their commitment to long-term partnerships. Capnamic's network includes successful founders and large corporations as Limited Partners, providing access to valuable expertise and connections for their portfolio companies. They invest in tech startups at the early stages, from pre-seed to Series A. With their industry network, hands-on approach and their support functions such as marketing and finance, they help to turn a business idea into a fully-fledged company. As a VC firm with people on the ground in Cologne, Berlin, and Munich they have a deep-rooted network in the German tech scene. They strongly focus their investment activities on Germany and the German-speaking regions. That doesn’t rule out deals elsewhere - but they certainly need extra conviction then.
CommerzVentures
CommerzVentures is an independent and return-oriented VC firm focused on backing visionary founders shaping the future of FinTech. They manage €550m across three funds. They invest in companies that leverage advanced data analytics and AI to drive tangible results, particularly in areas such as carbon emission management, agentic AI for financial services, and software management. Their strategy is focused on supporting companies that are at the forefront of vital industrial step-changes and can solve key problems for industries globally. They seek to invest in companies with proven track records and the potential for significant growth and global impact. CommerzVentures focuses on companies with a clear focus on addressing critical industry needs. For example, they invested in carbmee, an AI-powered carbon management software company, that enables businesses to manage, reduce, and report on their carbon emissions. This investment is in line with their belief that companies that address sustainability challenges and help businesses decarbonize their supply chains are key targets. Similarly, their investment in Unique, an AI platform for financial services, shows their interest in companies that can enhance efficiency across sectors like research, compliance, and KYC. Their approach involves leading funding rounds and actively participating in the growth of their portfolio companies. They offer strategic support and leverage their network to help companies expand into new markets, particularly the United States. The firm's managing partners express excitement in supporting their portfolio companies and driving innovation within the financial services industry and other sectors. CommerzVentures appears to be focused on being a value-add investor, leveraging their experience and resources to accelerate the growth of their portfolio companies. They aim to identify and support companies that can fundamentally transform industries, with a strong emphasis on sustainability, efficiency, and innovation. This holistic approach suggests they consider both the financial potential of their investments and the broader societal impact of the companies they support.
Creathor Ventures
Based on the available information, Creathor Ventures' investment thesis is centered around "backing the creators of our future". They appear to be active in both the Tech and Healthcare sectors. The firm is based in Germany. They express a desire to "learn more" about the tech and healthcare industries, implying that they are actively seeking new investment opportunities in these areas. They encourage potential portfolio companies to apply for careers, suggesting an interest in companies that are actively growing and hiring. While the provided data is limited, Creathor Ventures appears to be a venture capital firm focused on investing in innovative companies within the tech and healthcare sectors, with a particular emphasis on the German market.
Digital Health Ventures
Digital Health Ventures invests in pioneering digital health startups. They seek investment opportunities in companies focused on transforming healthcare through innovative technologies. The firm aims to leverage its strong network of experienced investors, founders, experts, and employees to support their portfolio companies. They are committed to actively engaging with their startups to help them succeed.
Earlybird Digital West
Earlybird Digital West is a venture capital firm that focuses on backing early-stage entrepreneurs in Europe's emerging tech sector. They invest from Pre-Seed to Series A, providing financial resources, strategic support, and access to an international network. The firm aims to partner with founders "from before the breakthrough," indicating a focus on innovative and potentially transformative companies. They look for companies specializing in innovation and aim to build lasting and impactful businesses. Earlybird also has a dedicated health fund, Earlybird Health, which suggests a separate focus on healthcare investments.
Elevat3 Capital Ltd
Elevat3 Capital, the venture capital arm of Christian Angermayer's Apeiron Investment Group, focuses on companies where they can influence or control triggers to create value for all stakeholders. They believe every company has between one and three "triggers" that, if executed successfully, will immediately bring the company to the next valuation level. Elevat3 deploys an extreme value-add and hands-on approach, serving as entrepreneurial, reliable, and long-term partners to their portfolio companies. They manage more than US$250m+ in Assets Under Management, primarily investing in high-growth tech companies across Europe, while also selectively pursuing deals in other geographies. Across the broader Apeiron universe, the portfolio encompasses more than 100 high-growth tech companies in Europe, North America, and Asia. Elevat3 aims to lead venture deals in Europe, providing support and capital to companies undergoing radical change in their respective industries. They look for opportunities to lead or co-lead rounds, typically with ticket sizes ranging from US$5-20m. The firm's approach aligns with Apeiron Investment Group's broader focus on Life Sciences, FinTech & Crypto, and Future Tech, and Experiences, Hospitality & Happiness, leveraging the resources and expertise of the larger organization.
Enjoy Venture
EnjoyVenture GmbH is a German venture capital firm that invests in technology-driven startups with high growth potential. They focus on seed and growth financing, particularly for spin-offs from universities, research institutes, and corporations. They aim to identify companies with visionary teams, disruptive potential, and the ability to transform or create new markets. EnjoyVenture actively supports its portfolio companies with a hands-on approach, leveraging its extensive network and experience to help them overcome challenges and achieve success. The firm looks for opportunities where they can play an active role in shaping the future and discovering new trends. They connect innovative business models to the future, partnering with entrepreneurs to achieve significant growth. They provide capital, expertise, and access to a broad network of co-investors and industry stakeholders. Their investment strategy involves close collaboration with portfolio companies from the early stages, providing guidance and support throughout their journey. EnjoyVenture also focuses on creating synergy within its portfolio, facilitating collaboration between companies to enhance their overall performance. They seek companies with exceptional teams displaying courage, persistence, and resilience.
Extorel GmbH
Extorel GmbH is the family office of the Strascheg family, acting as an independent institution advising the family on all investment decisions. Their investment strategy centers around diversification across a broad portfolio encompassing nearly all asset classes. The firm places a significant emphasis on alternative investments, including direct company holdings, liquid alternatives (hedge funds), private markets, and real estate. The firm aims to leverage Falk Strascheg's extensive experience as a successful venture investor in Germany and Europe.
FLORA Ventures
FLORA Ventures invests in purpose-driven entrepreneurs redefining the AgriFood industry. Their investment focus lies at the intersection of the AgriFood industry with planetary and human health. They are looking to back companies that address key challenges in the food system to improve outcomes for both people and the planet. While the specific investment strategy and manifesto aren't detailed on the homepage, the emphasis on 'purpose-driven' suggests a commitment to impact investing. Their involvement in conferences and events focused on food security, ESG, and the AgriFood ecosystem, demonstrates active engagement and knowledge leadership in this domain. Based on the news section, they seem to be actively looking for opportunities in the Israeli and Swiss AgriFood ecosystem. They're also interested in sustainability, as evidenced by their coverage in Forbes highlighting their launch to tackle food sustainability. Their focus spans both sponsoring industry events and actively participating in pitch nights and hackathons, pointing towards a multi-faceted approach to sourcing deals and supporting innovation. Flora Ventures is described as an experienced and complementary team of Agrifood and Tech investors, operators and venture builders.
Found Fair Ventures GmbH
Foundfair invests in startups that disrupt inefficient systems with smart ideas, combining engineering expertise and entrepreneurial drive to create scalable solutions with meaningful impact.
Freigeist Capital
Freigeist Capital invests in European deep tech startups that leverage emerging technologies (AI, Robotics, Synthetic Biology, Quantum Computing) to address global challenges and create scalable, long-term solutions. They focus on supporting founders with hands-on mentorship, long-term capital, and a collaborative approach to build industry-leading companies.
Freiraum Ventures
Freiraum Ventures focuses on early-stage startups with a strong emphasis on knowledge, education, and innovation. They invest in incorporated teams with ticket sizes between EUR 50k and 200k, aiming to be the first investor in the company. The fund is backed by the Strascheg Center for Entrepreneurship (SCE) and Prof. Dr. Falk F. Strascheg.
Fuse Venture Partners
Fuse Venture Partners operates as both a strategic advisor and a growth-stage venture capital investor. Their approach is two-pronged: they provide advisory services to high-growth tech companies and their investors, and they directly invest in European scale-ups. On the advisory side, they offer strategic consulting, transaction support (M&A, capital raising), and operational improvement services. Their team leverages experience in corporate finance, strategy, finance, and legal matters, combined with hands-on operational expertise to guide companies through strategic transformations. They aim to help CEOs and management teams remain focused on operations while Fuse handles strategic planning and execution. They have a track record of advising ventures on inorganic expansion plans and managing/executing numerous transactions across Europe and globally. On the investment side, Fuse Venture Partners acts as a general partner firm, raising capital from a network of limited partners. They focus on European scale-ups that have demonstrated product-market fit and are ready to scale, typically around the Series B stage. Their investment strategy is informed by their prior experience as principal investors and general partners, enabling them to offer valuable insights to founders, management teams, investors, and shareholders. They have a history of contributing to the creation of some of Europe’s largest unicorns, in partnership with venture management teams and leading technology investors. Fuse Venture Partners' mission is to accelerate innovation and value creation by guiding founders through key strategic transactions and partnering with investors to unlock the full potential of their portfolio companies. They aim to act as trusted advisors and operating partners to entrepreneurs, management teams, and investors alike.
GMPVC German Media Pool
German Media Pool (GMPVC) is a European venture capital firm specializing in a unique "media for equity" investment model. They primarily invest in consumer-facing startups, providing them with significant media presence across TV, radio, out-of-home advertising, print, and social media. The firm's core strategy revolves around using media as a strategic asset to drive rapid growth and brand recognition for its portfolio companies. GMPVC also makes selected cash investments through its associated venture capital fund, GMPVC Opportunities, complementing its media for equity approach. The firm aims to accelerate the growth of its portfolio companies and establish them as household names by providing tailored media service packages. This involves careful assessment of the startup's needs and designing a media strategy that maximizes impact and reach. By leveraging its network of media partners, GMPVC secures premium media placements that would be difficult for early-stage companies to access independently. Their investment model provides startups with access to a valuable resource often out of reach for cash-strapped ventures. GMPVC essentially transforms marketing spend into equity, aligning incentives for both the fund and the investee. The firm seeks to create a win-win scenario where the startup benefits from increased brand awareness and customer acquisition, and GMPVC benefits from the equity appreciation resulting from the accelerated growth. GMPVC focuses on supporting European startups in the consumer sector and leverages a diverse range of media channels to effectively reach target audiences and scale their businesses. The firm also employs a more traditional cash investment approach through GMPVC Opportunities in addition to Media-for-Equity deals.
Global Founders Capital
Global Founders Capital (GFC) is a global early-stage investor that empowers gifted entrepreneurs. They aim to back founders who start category-defining ventures, providing support from day zero through all stages of growth. GFC invests across all geographies, focusing on early-stage companies from pre-seed and seed and throughout their lifecycle.
Henkel Tech Ventures
Henkel Ventures is the Corporate Venture Capital arm of Henkel, a company known for building brands like Loctite, Schwarzkopf, and Persil. Their investment strategy revolves around providing funding combined with strategic partnerships to drive innovation and unlock growth for early-stage startups. They seek to shape the future through strategic investment, innovation, and partnership, leveraging Henkel's pioneering technologies, strong brands, and innovative business models to create a lasting impact. Henkel Ventures focuses on investing in startups that align with their focus on "Sustainovation" and "Digitalization." They work closely with Henkel's two business units, Henkel Consumer Brands and Henkel Adhesive Technologies, to drive co-innovation. Their approach is to provide not just financial backing but also build bridges to corporate resources and expertise to accelerate the growth and impact of their portfolio companies. Their legacy of entrepreneurship stems from Henkel's nearly 150-year history, starting with founder Fritz Henkel's vision. This entrepreneurial spirit remains at the core of Henkel Ventures, driving their pursuit of strategic partnerships and scouting for the next unicorns. They aim to carry on Henkel's legacy by turning visionary ideas into partnerships with meaningful innovations for the good of generations and financial success. Specifically, startups gain access to capital, expertise from over 3,000 Henkel R&D experts to refine their strategies and technologies, and a global network of co-investors and partners. This comprehensive support system is designed to empower startups, accelerate their growth, and maximize their impact within the market.
Henkel Ventures
Henkel Ventures, the corporate venture capital arm of Henkel, invests in early-stage startups with a focus on driving innovation and unlocking growth through strategic partnerships. They seek companies aligning with Henkel's two business units, Henkel Consumer Brands and Henkel Adhesive Technologies, to facilitate co-innovation in Sustainovation and Digitalization. Henkel Ventures aims to leverage its nearly 150-year legacy of market success, built on bold ideas and technologies, to shape the future by scouting for the next unicorns. The firm's investment strategy is centered around providing not just capital, but also expertise and a global network. They enable startups to scale their ideas, refine their strategies and technologies, and connect with like-minded co-investors and partners. By granting access to more than 3,000 Henkel R&D experts, Henkel Ventures empowers startups with corporate resources, and expertise to accelerate their growth and impact. They are committed to turning visionary ideas into partnerships with meaningful innovations for the good of generations and financial success. Henkel Ventures emphasizes professional investments and co-innovation to build a sustainable and digital future, aligning with Henkel's legacy by turning visionary ideas into partnerships and meaningful innovations. Their approach involves closely collaborating with Henkel’s business units to drive co-innovation and empower startups by bridging them to corporate resources and expertise.
K5 ADVISORS GmbH & Co. KG
K5 Advisors GmbH & Co. KG is an investment office that predominantly invests in real estate and alternative asset classes. The firm does not provide a detailed, multi-paragraph investment thesis on their website. Information is limited, but the core focus appears to be allocating capital into these two areas.
MTE MedTech Entrepreneurs
MTE MedTech Entrepreneurs focuses on investing in life-changing Medical technologies and Digital Health Applications, aiming to accelerate the future of healthcare. They believe that MedTech innovations will lead to a better and longer life for everyone and aims to facilitate the creation of new opportunities and set new standards of care. They target companies with defendable IP and measurable advantages, specifically focusing on the convergence of Digital, Healthcare, and Technology. The firm emphasizes investing before early-stage angels and bridges the gap between angels and larger venture capital funds. They believe that for MedTech companies, an exit is obligatory, aiming for high multiples and few losses, avoiding the "unicorn" chase. Their commercialization approach includes targeting new reimbursement (NUBs) and working with industry experts, leveraging a MedTech track record, comprehensive operational support, cooperative milestone management, an international distribution network, and access to Key Opinion Leaders. MTE also addresses the typical challenges faced by academically rooted start-ups, namely corporate governance, market knowledge, and network. They provide strategic advice and assistance in these areas. They offer operational support for inexperienced founders and review business plans, roadmaps, milestones, and KPIs. They provide start-ups 200-man-years of experience in the health care industry, comprehensive operational support, and access to Key Opinion Leaders. They perform a unique evaluation method for management and provide direct access to a complete bandwidth of players in healthcare with a reliable network.